You are here
Treatment with a synthetic antimalarial drug
Psoriasis - Treatment with a synthetic antimalarial drug Factor
Last reviewed for CCPS 10 June 2012.
Investigative Documents
Claimant Report - Treatment with a synthetic antimalarial drug - Psoriasis [CR9238] Medical Report - Treatment with a synthetic antimalarial drug - Psoriasis [MR9311] Preliminary questions [34234]
34236 the veteran has been treated with a synthetic antimalarial drug at some time. 34237 — the veteran has established the causal connection between the treatment with a synthetic antimalarial drug and VEA service for psoriasis. 34238 — the veteran has established the causal connection between the treatment with a synthetic antimalarial drug and VEA service for the clinical onset of psoriasis. 34242 — the veteran has established the causal connection between the treatment with a synthetic antimalarial drug and operational service for the clinical onset of psoriasis. or 34243 — the veteran has established the causal connection between the treatment with a synthetic antimalarial drug and eligible service for the clinical onset of psoriasis. or 34239 — the veteran has established the causal connection between the treatment with a synthetic antimalarial drug and VEA service for the clinical worsening of psoriasis. 34244 — the veteran has established the causal connection between the treatment with a synthetic antimalarial drug and operational service for the clinical worsening of psoriasis. or 34245 — the veteran has established the causal connection between the treatment with a synthetic antimalarial drug and eligible service for the clinical worsening of psoriasis. Clinical onset and operational service [34242] or
34255 for treatment of the identified illness or injury, the veteran was treated with a synthetic antimalarial drug at the time of the clinical onset of the condition under consideration. 34257 — the identified illness or injury for which the veteran was treated with a synthetic antimalarial drug is causally related to operational service. Clinical onset and eligible service [34243] or
34255 for treatment of the identified illness or injury, the veteran was treated with a synthetic antimalarial drug at the time of the clinical onset of the condition under consideration. 34258 — the identified illness or injury for which the veteran was treated with a synthetic antimalarial drug is causally related to eligible service. Clinical worsening and operational service [34244] or
34256 for treatment of the identified illness or injury, the veteran was treated with a synthetic antimalarial drug at the time of the clinical worsening of the condition under consideration. 34257 — the identified illness or injury for which the veteran was treated with a synthetic antimalarial drug is causally related to operational service. Clinical worsening and eligible service [34245] or
34256 for treatment of the identified illness or injury, the veteran was treated with a synthetic antimalarial drug at the time of the clinical worsening of the condition under consideration. 34258 — the identified illness or injury for which the veteran was treated with a synthetic antimalarial drug is causally related to eligible service.